Td Waterhouse Canada Inc. Dia Medica Therapeutics Inc. Transaction History
Td Waterhouse Canada Inc.
- $14.8 Trillion
- Q2 2024
A detailed history of Td Waterhouse Canada Inc. transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 1,070 shares of DMAC stock, worth $4,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,070
Previous 1,070
-0.0%
Holding current value
$4,708
Previous $3.88 Million
7.72%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DMAC
# of Institutions
36Shares Held
3.87MCall Options Held
1.3KPut Options Held
1K-
Vanguard Group Inc Valley Forge, PA1.02MShares$4.48 Million0.0% of portfolio
-
First Manhattan CO New York, NY839KShares$3.69 Million0.01% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX483KShares$2.12 Million3.48% of portfolio
-
Bleichroeder LP New York, NY382KShares$1.68 Million0.41% of portfolio
-
Geode Capital Management, LLC Boston, MA237KShares$1.04 Million0.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $116M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...